Literature DB >> 30937868

Pericytes in the Liver.

Enis Kostallari1, Vijay H Shah2.   

Abstract

Liver pericytes, commonly named hepatic stellate cells (HSCs), reside in the space between liver sinusoidal endothelial cells (LSECs) and hepatocytes. They display important roles in health and disease. HSCs ensure the storage of the majority of vitamin A in a healthy body, and they represent the major source of fibrotic tissue in liver disease. Surrounding cells, such as LSECs, hepatocytes, and Kupffer cells, present a significant role in modulating HSC behavior. Therapeutic strategies against liver disease are being currently developed, where HSCs represent an ideal target. In this chapter, we will discuss HSC quiescence and activation in the context of healthy liver and diseases, such as fibrosis, steatohepatitis, and hepatocellular carcinoma.

Entities:  

Keywords:  Fibrosis; Healthy liver; Hepatic stellate cells; Hepatocellular carcinoma; Hepatocytes; Kupffer cells; Liver; NAFLD; NASH; Pericytes; Regeneration; Sinusoidal endothelial cells

Mesh:

Year:  2019        PMID: 30937868      PMCID: PMC7137998          DOI: 10.1007/978-3-030-11093-2_9

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  93 in total

Review 1.  Liver fibrosis: Direct antifibrotic agents and targeted therapies.

Authors:  Detlef Schuppan; Muhammad Ashfaq-Khan; Ai Ting Yang; Yong Ook Kim
Journal:  Matrix Biol       Date:  2018-04-12       Impact factor: 11.583

Review 2.  Hepatic stem cell niches.

Authors:  Claus Kordes; Dieter Häussinger
Journal:  J Clin Invest       Date:  2013-05-01       Impact factor: 14.808

3.  A secreted form of ADAM9 promotes carcinoma invasion through tumor-stromal interactions.

Authors:  Antonio Mazzocca; Roberto Coppari; Raffaella De Franco; Je-Yoel Cho; Towia A Libermann; Massimo Pinzani; Alex Toker
Journal:  Cancer Res       Date:  2005-06-01       Impact factor: 12.701

Review 4.  Retinoic acids and hepatic stellate cells in liver disease.

Authors:  Young-Sun Lee; Won-Il Jeong
Journal:  J Gastroenterol Hepatol       Date:  2012-03       Impact factor: 4.029

Review 5.  Hepatic stellate cell progenitor cells.

Authors:  Kinji Asahina
Journal:  J Gastroenterol Hepatol       Date:  2012-03       Impact factor: 4.029

6.  Primary rat and mouse hepatic stellate cells express the macrophage inhibitor cytokine interleukin-10 during the course of activation In vitro.

Authors:  K C Thompson; A Trowern; A Fowell; M Marathe; C Haycock; M J Arthur; N Sheron
Journal:  Hepatology       Date:  1998-12       Impact factor: 17.425

7.  Searching for common stem cells of the hepatic and hematopoietic systems in the human fetal liver: CD34+ cytokeratin 7/8+ cells express markers for stellate cells.

Authors:  David L Suskind; Marcus O Muench
Journal:  J Hepatol       Date:  2004-02       Impact factor: 25.083

8.  Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.

Authors:  Bart Staels; Anne Rubenstrunk; Benoit Noel; Géraldine Rigou; Philippe Delataille; Lesley J Millatt; Morgane Baron; Anthony Lucas; Anne Tailleux; Dean W Hum; Vlad Ratziu; Bertrand Cariou; Rémy Hanf
Journal:  Hepatology       Date:  2013-10-29       Impact factor: 17.425

9.  Mesenchymal origin of hepatic stellate cells, submesothelial cells, and perivascular mesenchymal cells during mouse liver development.

Authors:  Kinji Asahina; Shirley Y Tsai; Peng Li; Mamoru Ishii; Robert E Maxson; Henry M Sucov; Hidekazu Tsukamoto
Journal:  Hepatology       Date:  2009-03       Impact factor: 17.425

10.  Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice.

Authors:  Kouichi Miura; Ling Yang; Nico van Rooijen; David A Brenner; Hirohide Ohnishi; Ekihiro Seki
Journal:  Hepatology       Date:  2013-02       Impact factor: 17.425

View more
  8 in total

1.  Hepatic stellate cell autophagy inhibits extracellular vesicle release to attenuate liver fibrosis.

Authors:  Jinhang Gao; Bo Wei; Thiago M de Assuncao; Zhikui Liu; Xiao Hu; Samar Ibrahim; Shawna A Cooper; Sheng Cao; Vijay H Shah; Enis Kostallari
Journal:  J Hepatol       Date:  2020-05-08       Impact factor: 25.083

2.  Hepatic stellate cells - from past till present: morphology, human markers, human cell lines, behavior in normal and liver pathology.

Authors:  Rada Teodora Sufleţel; Carmen Stanca Melincovici; Bogdan Alexandru Gheban; Zaharie Toader; Carmen Mihaela Mihu
Journal:  Rom J Morphol Embryol       Date:  2020 Jul-Sep       Impact factor: 1.033

Review 3.  Targeting the Wnt Signaling Pathway in Liver Fibrosis for Drug Options: An Update.

Authors:  Kristina Duspara; Kristina Bojanic; Josipa Ivanusic Pejic; Lucija Kuna; Tea Omanovic Kolaric; Vjera Nincevic; Robert Smolic; Aleksandar Vcev; Marija Glasnovic; Ines Bilic Curcic; Martina Smolic
Journal:  J Clin Transl Hepatol       Date:  2021-09-13

Review 4.  The versatility of macrophage heterogeneity in liver fibrosis.

Authors:  Chun-Chen Gao; Jian Bai; Hua Han; Hong-Yan Qin
Journal:  Front Immunol       Date:  2022-08-05       Impact factor: 8.786

5.  Coordinated signaling of activating transcription factor 6α and inositol-requiring enzyme 1α regulates hepatic stellate cell-mediated fibrogenesis in mice.

Authors:  Fei Xue; Jianwen Lu; Samuel C Buchl; Liankang Sun; Vijay H Shah; Harmeet Malhi; Jessica L Maiers
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-03-17       Impact factor: 4.052

Review 6.  Mesenchymal Stem Cells in the Adult Human Liver: Hype or Hope?

Authors:  Irina V Kholodenko; Leonid K Kurbatov; Roman V Kholodenko; Garik V Manukyan; Konstantin N Yarygin
Journal:  Cells       Date:  2019-09-22       Impact factor: 6.600

Review 7.  Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy.

Authors:  Yasuko Iwakiri; Jonel Trebicka
Journal:  JHEP Rep       Date:  2021-06-04

Review 8.  Corneal Opacity: Cell Biological Determinants of the Transition From Transparency to Transient Haze to Scarring Fibrosis, and Resolution, After Injury.

Authors:  Steven E Wilson; Lycia Pedral Sampaio; Thomas Michael Shiju; Guilherme S L Hilgert; Rodrigo Carlos de Oliveira
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-01-03       Impact factor: 4.799

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.